HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcare centers and increases the length of stay in ICU.

Scope of the Report:

The worldwide market for Hospital-Acquired Pneumonia Prevention is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Hospital-Acquired Pneumonia Prevention in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Halyard Health

Sage Products LLC

Intersurgical Ltd.

Medline Industries

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oral Care Kit

Toothbrush

Swab

Moisturizer

Mouth Wash

Suction Tools

Market Segment by Applications, can be divided into

Hospitals

Rehabilitation Centers

Home Care Settings

There are 15 Chapters to deeply display the global Hospital-Acquired Pneumonia Prevention market.

Chapter 1, to describe Hospital-Acquired Pneumonia Prevention Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hospital-Acquired Pneumonia Prevention, with sales, revenue, and price of Hospital-Acquired Pneumonia Prevention, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hospital-Acquired Pneumonia Prevention, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hospital-Acquired Pneumonia Prevention market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hospital-Acquired Pneumonia Prevention sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Hospital-Acquired Pneumonia Prevention Introduction

1.2 Market Analysis by Type

1.2.1 Oral Care Kit

1.2.2 Toothbrush

1.2.3 Swab

1.2.4 Moisturizer

1.2.5 Mouth Wash

1.2.6 Suction Tools

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Rehabilitation Centers

1.3.3 Home Care Settings

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Halyard Health

2.1.1 Business Overview

2.1.2 Hospital-Acquired Pneumonia Prevention Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Halyard Health Hospital-Acquired Pneumonia Prevention Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sage Products LLC

2.2.1 Business Overview

2.2.2 Hospital-Acquired Pneumonia Prevention Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sage Products LLC Hospital-Acquired Pneumonia Prevention Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Intersurgical Ltd.

2.3.1 Business Overview

2.3.2 Hospital-Acquired Pneumonia Prevention Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Intersurgical Ltd. Hospital-Acquired Pneumonia Prevention Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Medline Industries

2.4.1 Business Overview

2.4.2 Hospital-Acquired Pneumonia Prevention Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Medline Industries Hospital-Acquired Pneumonia Prevention Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Hospital-Acquired Pneumonia Prevention Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Hospital-Acquired Pneumonia Prevention Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Hospital-Acquired Pneumonia Prevention Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Hospital-Acquired Pneumonia Prevention Manufacturer Market Share in 2017

3.3.2 Top 6 Hospital-Acquired Pneumonia Prevention Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Hospital-Acquired Pneumonia Prevention Market Analysis by Regions

4.1 Global Hospital-Acquired Pneumonia Prevention Sales, Revenue and Market Share by Regions

4.1.1 Global Hospital-Acquired Pneumonia Prevention Sales and Market Share by Regions (2013-2018)

4.1.2 Global Hospital-Acquired Pneumonia Prevention Revenue and Market Share by Regions (2013-2018)

4.2 North America Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

4.3 Europe Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

4.5 South America Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

5 North America Hospital-Acquired Pneumonia Prevention by Countries

5.1 North America Hospital-Acquired Pneumonia Prevention Sales, Revenue and Market Share by Countries

5.1.1 North America Hospital-Acquired Pneumonia Prevention Sales and Market Share by Countries (2013-2018)

5.1.2 North America Hospital-Acquired Pneumonia Prevention Revenue and Market Share by Countries (2013-2018)

5.2 United States Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

5.3 Canada Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

5.4 Mexico Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

6 Europe Hospital-Acquired Pneumonia Prevention by Countries

6.1 Europe Hospital-Acquired Pneumonia Prevention Sales, Revenue and Market Share by Countries

6.1.1 Europe Hospital-Acquired Pneumonia Prevention Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Hospital-Acquired Pneumonia Prevention Revenue and Market Share by Countries (2013-2018)

6.2 Germany Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

6.3 UK Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

6.4 France Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

6.5 Russia Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

6.6 Italy Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

7 Asia-Pacific Hospital-Acquired Pneumonia Prevention by Countries

7.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Revenue and Market Share by Countries (2013-2018)

7.2 China Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

7.3 Japan Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

7.4 Korea Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

7.5 India Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

8 South America Hospital-Acquired Pneumonia Prevention by Countries

8.1 South America Hospital-Acquired Pneumonia Prevention Sales, Revenue and Market Share by Countries

8.1.1 South America Hospital-Acquired Pneumonia Prevention Sales and Market Share by Countries (2013-2018)

8.1.2 South America Hospital-Acquired Pneumonia Prevention Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

8.3 Argentina Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

8.4 Colombia Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

9 Middle East and Africa Hospital-Acquired Pneumonia Prevention by Countries

9.1 Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Hospital-Acquired Pneumonia Prevention Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Hospital-Acquired Pneumonia Prevention Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

9.3 UAE Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

9.4 Egypt Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

9.5 Nigeria Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

9.6 South Africa Hospital-Acquired Pneumonia Prevention Sales and Growth Rate (2013-2018)

10 Global Hospital-Acquired Pneumonia Prevention Market Segment by Type

10.1 Global Hospital-Acquired Pneumonia Prevention Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Hospital-Acquired Pneumonia Prevention Sales and Market Share by Type (2013-2018)

10.1.2 Global Hospital-Acquired Pneumonia Prevention Revenue and Market Share by Type (2013-2018)

10.2 Oral Care Kit Sales Growth and Price

10.2.1 Global Oral Care Kit Sales Growth (2013-2018)

10.2.2 Global Oral Care Kit Price (2013-2018)

10.3 Toothbrush Sales Growth and Price

10.3.1 Global Toothbrush Sales Growth (2013-2018)

10.3.2 Global Toothbrush Price (2013-2018)

10.4 Swab Sales Growth and Price

10.4.1 Global Swab Sales Growth (2013-2018)

10.4.2 Global Swab Price (2013-2018)

10.5 Moisturizer Sales Growth and Price

10.5.1 Global Moisturizer Sales Growth (2013-2018)

10.5.2 Global Moisturizer Price (2013-2018)

10.6 Mouth Wash Sales Growth and Price

10.6.1 Global Mouth Wash Sales Growth (2013-2018)

10.6.2 Global Mouth Wash Price (2013-2018)

10.7 Suction Tools Sales Growth and Price

10.7.1 Global Suction Tools Sales Growth (2013-2018)

10.7.2 Global Suction Tools Price (2013-2018)

11 Global Hospital-Acquired Pneumonia Prevention Market Segment by Application

11.1 Global Hospital-Acquired Pneumonia Prevention Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Rehabilitation Centers Sales Growth (2013-2018)

11.4 Home Care Settings Sales Growth (2013-2018)

12 Hospital-Acquired Pneumonia Prevention Market Forecast (2018-2023)

12.1 Global Hospital-Acquired Pneumonia Prevention Sales, Revenue and Growth Rate (2018-2023)

12.2 Hospital-Acquired Pneumonia Prevention Market Forecast by Regions (2018-2023)

12.2.1 North America Hospital-Acquired Pneumonia Prevention Market Forecast (2018-2023)

12.2.2 Europe Hospital-Acquired Pneumonia Prevention Market Forecast (2018-2023)

12.2.3 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Forecast (2018-2023)

12.2.4 South America Hospital-Acquired Pneumonia Prevention Market Forecast (2018-2023)

12.2.5 Middle East and Africa Hospital-Acquired Pneumonia Prevention Market Forecast (2018-2023)

12.3 Hospital-Acquired Pneumonia Prevention Market Forecast by Type (2018-2023)

12.3.1 Global Hospital-Acquired Pneumonia Prevention Sales Forecast by Type (2018-2023)

12.3.2 Global Hospital-Acquired Pneumonia Prevention Market Share Forecast by Type (2018-2023)

12.4 Hospital-Acquired Pneumonia Prevention Market Forecast by Application (2018-2023)

12.4.1 Global Hospital-Acquired Pneumonia Prevention Sales Forecast by Application (2018-2023)

12.4.2 Global Hospital-Acquired Pneumonia Prevention Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Hospital-Acquired Pneumonia Prevention Picture

Table Product Specifications of Hospital-Acquired Pneumonia Prevention

Figure Global Sales Market Share of Hospital-Ac